← Eichor
Condition: Tumor Colorectal Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tumor Colorectal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07608120AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NA · 1 location(s) · Guo ShiWei · NCT06632886Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a Nati
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06350370Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06369259Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT05768503Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06929013ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Phase N/A · 16 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05787197Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
NA · 2 location(s) · Copenhagen University Hospital at Herlev · NCT06802991Personalized Health Self-Management Training for Colorectal Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT05984589Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary
NA · 1 location(s) · KU Leuven · NCT06274190Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal L
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05195710Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Phase 2 · 1 location(s) · Xinqiao Hospital of Chongqing · NCT06279351Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Phase 2 · 9 location(s) · Rutgers, The State University of New Jersey · NCT05806931Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal
Phase 2 · 28 location(s) · Gruppo Oncologico del Nord-Ovest · NCT07407465A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunoth
Phase 2 · 1 location(s) · Tao Zhang · NCT07239466Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · 48 location(s) · AbbVie · NCT07023289A Multi-center Investigation of Family Health.
Phase N/A · 1 location(s) · Odense University Hospital · NCT06433349RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NA · 9 location(s) · University of Aarhus · NCT06614647Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · 13 location(s) · National Cancer Institute (NCI) · NCT06696768Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorect
Phase 2 · 1 location(s) · Fudan University · NCT05963490Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer
Phase N/A · 1 location(s) · Consorci Sanitari de Terrassa · NCT03853733Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer (PRORECT)
NA · 9 location(s) · Alexander Valdman · NCT04525989Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advance
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07594925Establishment of a Tumor Bank for Blood Samples
Phase N/A · 6 location(s) · Medical University of Vienna · NCT01763125Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treat
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07047560AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
Phase 3 · 2 location(s) · Akeso · NCT06951503
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.